The Edit · Founder Insights
Healthspan is the number of years you live in good health, not just the number of years you live. Here's what it means, why it matters, and what to do about it.

Healthspan is the number of years you live in good health, free from significant physical or mental limitations. It is the timeline that matters more than lifespan, because the gap between the two — the years a person lives with disability, dependence, or chronic disease — is what determines whether old age is a destination or a long decline. In Singapore, that gap is currently around 9 to 10 years.
TL;DR
- Healthspan = the years you live in full health. Lifespan = the years you live, full stop. The difference is the disability gap.
- Singapore's life expectancy is among the world's highest at 83 years; healthy life expectancy is around 73-74. The 9-10 year gap is largely preventable.
- Four factors carry most of the explanatory weight: muscle mass, cardiorespiratory fitness, stability, and metabolic health. Strength training and Zone 2 cardio target all four.
- By 2030 roughly one in four Singaporeans will be 65 or older. The healthspan question is no longer optional in this country.
- Most healthspan loss happens before symptoms. Screening in your 40s and 50s — not your 70s — is when the intervention works.
Healthspan vs lifespan, the distinction that matters
Lifespan is how long you live. Healthspan is how long you live well. The two figures are tracked separately by the World Health Organization, which publishes both life expectancy and healthy life expectancy for every country. The difference between them — the years a person spends with disability, chronic disease, or significant functional limitation — is what gets compressed by good training and decompressed by neglect.
The framing matters because most people optimise for the wrong target. A person who reaches 85 with the last 12 years spent in a wheelchair, on multiple medications, and dependent on family for activities of daily living has a long lifespan and a short healthspan. A person who reaches 82 walking unaided, lifting their own groceries, and travelling alone has a shorter lifespan and a much longer healthspan. The second life is the one almost everyone says they want when you ask. The first is the one we drift into by default.
The clinical literature now consistently treats healthspan as the variable worth intervening on. The reason: lifespan is largely a fixed function of biology and circumstance, but healthspan responds dramatically to a small set of trainable inputs.
The Singapore context, and why the gap is bigger here than it looks
Singapore has one of the world's highest life expectancies. By 2030, around one in four Singaporeans will be 65 or older — a demographic shift sharper than almost any country on Earth has experienced in peacetime.
The healthy life expectancy gap is the part of the picture most people miss. Singapore's life expectancy at birth sits at roughly 83 years. The healthy life expectancy figure — the years lived in full functional independence — is closer to 73-74. That delta of 9-10 years is what shows up in clinical practice as the late-50s and 60s slowdown, the 70s admissions for falls and metabolic disease, the 80s descent into dependence. I have written about Singapore's ageing trajectory before; the headline is that the gap is real, it is widening, and it is largely preventable through interventions started decades earlier.
Singapore's clinical infrastructure has begun to respond. The Ministry of Health's Healthier SG initiative shifts general practice toward chronic-disease prevention, and the geriatric medicine community has issued 2022 Clinical Practice Guidelines for Sarcopenia that mandate progressive resistance training as first-line treatment for the condition that most directly compresses healthspan in older adults. The infrastructure is real. What's missing for most people is the connection between today's training and the version of themselves that walks into a clinic at 75.
The four factors that decide your healthspan
The trial evidence converges on four pillars. Get these right and your healthspan curve flattens; get them wrong and it falls off a cliff in the 70s.
Body composition. Skeletal muscle mass is one of the strongest predictors of late-life independence in the literature. Muscle mass falls roughly 1% per year after the 30s in untrained adults. By the 70s, an untrained person has lost 30-50% of the muscle they had at 25. The condition is called sarcopenia, and it is reversible with structured resistance training even in the 80s. Body composition also captures visceral fat, which drives metabolic disease independent of body weight.
Cardiorespiratory fitness. VO2 max — the maximum rate at which your body can use oxygen — is the single strongest predictor of all-cause mortality across age groups. A 2018 cohort study of 122,000 adults published in JAMA found that elite cardiorespiratory fitness was associated with a 80% lower mortality risk versus the lowest fitness category. The signal was stronger than the protective effect of being a non-smoker, having normal blood pressure, or being non-diabetic.
Stability. The ability to maintain balance under load, transition between positions, and recover from perturbation. Stability is the pillar most under-trained in commercial gyms because it doesn't show up in mirror metrics. It shows up in the late-life fall statistics: a fall in a 75-year-old is one of the most consequential clinical events in geriatric medicine, and stability training is one of the few interventions with strong trial evidence for fall prevention.
Strength. Maximum force production, especially through the legs and grip. Grip strength alone predicts all-cause mortality independent of body composition, age, and most cardiovascular risk factors. The PURE study followed 140,000 adults across 17 countries and found that every 5 kg drop in handgrip strength carried a 16% increase in mortality risk over four years.
All four pillars respond to the same core training inputs: resistance training two to three times per week, cardiovascular work hitting both Zone 2 and high-intensity intervals, and movement quality that gets reassessed periodically. The dose is unglamorous but small. Three hours a week of structured work captures most of the available benefit.
Healthspan compresses when you train. It expands when you don't. There is no third option, and the difference between the two paths is decided in your 40s and 50s, not your 70s.
What to measure if you want to know where you stand
If you can't measure it, you can't move it. The four pillars correspond to four sets of measurements that any trained clinician or qualified assessment can capture in 60 minutes. The thresholds below are calibrated to the AWGS 2019 consensus for Asian adults plus published cardiovascular and stability norms.
Body composition. Skeletal muscle index (SMI) measured via bioimpedance or DXA. AWGS thresholds: below 7.0 kg/m² in men, below 5.7 kg/m² in women is the sarcopenia diagnostic threshold. Waist-to-height ratio above 0.5 is the metabolic risk threshold for visceral adiposity.
Cardiorespiratory fitness. VO2 max via direct measurement (treadmill or bike protocol with gas analysis) or estimated via heart rate recovery. A heart rate recovery below 12 bpm in the first minute after peak exercise is a clinical red flag for cardiovascular mortality risk.
Stability. Y-Balance Test for lower-limb dynamic stability, single-leg-stance time, and the Timed Up and Go for older adults. Asymmetry above 4 cm on the Y-Balance Test is a clinically meaningful flag for injury risk.
Strength. Handgrip dynamometer (AWGS thresholds: below 28 kg men, below 18 kg women) and the 5-time chair stand test (above 12 seconds is the threshold for low physical performance).
These are the numbers that decide whether the next two decades go well. The Catalyst Healthspan Assessment measures all of them in a single 60-minute session and outputs a Healthspan Score on a 0-10 scale, calibrated against the AWGS thresholds and our own studio data.
What to do about it, regardless of where you start
The training prescription is unglamorous and almost universally applicable. Resistance training two to three times per week, hitting compound movements (squats, hip hinges, presses, pulls, carries) with progressive load. Zone 2 cardiovascular work for 90 to 180 minutes per week, plus one or two short high-intensity intervals per week. A handful of stability and mobility inputs woven through both. Total time commitment: under three hours per week of dedicated training, plus walking and movement throughout the day.
What changes with age is not the prescription but the execution risk. A person starting at 55 with low baseline strength needs a longer ramp, a more cautious load progression, and probably a coach for the first six months. A person starting at 35 can absorb mistakes the older person can't. The window for getting it right widens the earlier you start, but the intervention works at every age — the trial evidence on resistance training in adults over 80 is unambiguous.
If you take one thing from this post: healthspan is decided by what you do every Tuesday at 7am, not what you do for two weeks before a holiday. The compounding works in both directions. Start, measure, adjust, continue.
Frequently asked questions
Q. What is the difference between healthspan and lifespan?
Lifespan is how long you live. Healthspan is how long you live in good health, free from significant disability or chronic disease. In Singapore, the gap between the two is roughly 9-10 years on average; that gap is the time spent managing illness or losing independence at the end of life. The healthspan framing optimises for the years you live well rather than just the years you live.
Q. Can I improve my healthspan in my 50s or 60s?
Yes. The trial evidence on progressive resistance training in adults aged 60+ is unambiguous: strength gains begin within four weeks, become clinically meaningful by 16 weeks, and continue compounding for years. The earlier you start the more reversal is possible, but the intervention works at every age — including in adults in their 80s.
Q. What's the single most important thing for healthspan?
If you had to pick one, muscle mass and strength. Skeletal muscle is the strongest single predictor of late-life independence in the literature, and it's the pillar that responds fastest to training. Cardiorespiratory fitness (VO2 max) is a close second. The good news: the same compound resistance training that builds muscle also raises VO2 max indirectly through improved metabolic health.
Q. How is healthspan measured in Singapore?
Healthspan itself is a population-level construct (healthy life expectancy minus disability years). At the individual level, it's measured by proxy through the four pillars: body composition, cardiorespiratory fitness, stability, and strength. The Catalyst Healthspan Assessment uses the AWGS 2019 thresholds for sarcopenia plus published cardiovascular and stability norms to output a 0-10 score. Geriatric clinics use the same diagnostic axes for older adults.
Q. How does healthspan relate to longevity?
Healthspan is the quality dimension of longevity; lifespan is the quantity dimension. Most people equate the two and assume that longer life automatically means better life. The data says otherwise — life expectancy in developed countries has plateaued or declined slightly, but disability years have grown. The longevity question worth asking isn't just "how long?" but "how well, for how long?" Healthspan is the answer to the second question.
Citations
World Health Organization. Life expectancy and Healthy life expectancy data. Global Health Observatory. who.int
Singapore Department of Statistics, National Population and Talent Division. Population trends and projections. population.gov.sg
Mandsager K, Harb S, Cremer P, et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 1(6), e183605. pubmed.ncbi.nlm.nih.gov
Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 386(9990), 266–273. pubmed.ncbi.nlm.nih.gov
Chen LK, Woo J, Assantachai P, et al. (2020). Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21(3), 300–307. jamda.com
Lim WS, Cheong CY, Lim JP, et al. (2022). Singapore Clinical Practice Guidelines for Sarcopenia. The Journal of Frailty & Aging, 11(4), 348–369. springer.com

